Contractors can use the app to validate designs and rebuild an architect’s work very quickly.

Unknowns are inertial (hence regulations can be enablers); and there are also clear opportunities and support to try and test new ideas and processes e.g.A combination of developing science and clear and joined up regulation e.g.

pharmacopeia and guidance, could help both the manufacturers and the biogenic solvent supply chain.Very clear and appropriate specifications and standards could help to accelerate the investment in and development of biogenic solvents, transitions, and approvals..It was noted that there are streams of scientific development in Al models which can help predict the production of harmful impurities and detect these impurities cheaply at parts per billion and parts per trillion levels.. Standards are not just set by regulators.

Any party that sets specifications helps to create a myriad of different standards.Consistent requirements across jurisdictions and customers could accelerate progress..

If the change to biogenic solvents can be made easier from a regulatory perspective, the next question is about the economics and supply Vs demand.

If reducing usage and waste along with increased recycling can lead the way, then the unit cost of the solvent becomes less and less relevant..Using Design for Manufacture and Assembly (DfMA) adds value at every stage of the design and build process, by identifying opportunities for standardisation of components and / or processes.

It brings the principles, experience and successes of the manufacturing industry to construction – with all the associated benefits in terms of reducing cost and waste, while increasing quality and efficiency.(Read more about DfMA.

M&E systems fit naturally with DfMA.Many processes and components are already standard.